nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefoxitin—Azotaemia—Vismodegib—skin cancer	0.0465	0.0465	CcSEcCtD
Cefoxitin—Superinfection—Fluorouracil—skin cancer	0.0318	0.0318	CcSEcCtD
Cefoxitin—Induration—Imiquimod—skin cancer	0.0292	0.0292	CcSEcCtD
Cefoxitin—Local reaction—Imiquimod—skin cancer	0.0236	0.0236	CcSEcCtD
Cefoxitin—Induration—Bleomycin—skin cancer	0.0207	0.0207	CcSEcCtD
Cefoxitin—Local reaction—Bleomycin—skin cancer	0.0168	0.0168	CcSEcCtD
Cefoxitin—Nephropathy toxic—Bleomycin—skin cancer	0.0161	0.0161	CcSEcCtD
Cefoxitin—Tenderness—Imiquimod—skin cancer	0.015	0.015	CcSEcCtD
Cefoxitin—Rash maculo-papular—Vemurafenib—skin cancer	0.0139	0.0139	CcSEcCtD
Cefoxitin—Vaginal inflammation—Imiquimod—skin cancer	0.0131	0.0131	CcSEcCtD
Cefoxitin—Local reaction—Fluorouracil—skin cancer	0.013	0.013	CcSEcCtD
Cefoxitin—Vaginal infection—Imiquimod—skin cancer	0.0123	0.0123	CcSEcCtD
Cefoxitin—Hepatic function abnormal—Imiquimod—skin cancer	0.0108	0.0108	CcSEcCtD
Cefoxitin—Tenderness—Bleomycin—skin cancer	0.0106	0.0106	CcSEcCtD
Cefoxitin—Cholestasis—Temozolomide—skin cancer	0.0103	0.0103	CcSEcCtD
Cefoxitin—Dermatitis exfoliative—Imiquimod—skin cancer	0.01	0.01	CcSEcCtD
Cefoxitin—Toxic epidermal necrolysis—Vemurafenib—skin cancer	0.01	0.01	CcSEcCtD
Cefoxitin—Eosinophilia—Vemurafenib—skin cancer	0.00951	0.00951	CcSEcCtD
Cefoxitin—Stevens-Johnson syndrome—Vemurafenib—skin cancer	0.00849	0.00849	CcSEcCtD
Cefoxitin—Tenderness—Fluorouracil—skin cancer	0.00826	0.00826	CcSEcCtD
Cefoxitin—Aplastic anaemia—Dactinomycin—skin cancer	0.00812	0.00812	CcSEcCtD
Cefoxitin—Vaginal inflammation—Temozolomide—skin cancer	0.00782	0.00782	CcSEcCtD
Cefoxitin—Phlebitis—Bleomycin—skin cancer	0.00781	0.00781	CcSEcCtD
Cefoxitin—Pancytopenia—Imiquimod—skin cancer	0.00778	0.00778	CcSEcCtD
Cefoxitin—Pain—Vismodegib—skin cancer	0.00756	0.00756	CcSEcCtD
Cefoxitin—Candida infection—Temozolomide—skin cancer	0.00747	0.00747	CcSEcCtD
Cefoxitin—Vaginal infection—Temozolomide—skin cancer	0.00739	0.00739	CcSEcCtD
Cefoxitin—Aplastic anaemia—Temozolomide—skin cancer	0.00735	0.00735	CcSEcCtD
Cefoxitin—Phlebitis—Dactinomycin—skin cancer	0.00729	0.00729	CcSEcCtD
Cefoxitin—Erythema multiforme—Vemurafenib—skin cancer	0.00727	0.00727	CcSEcCtD
Cefoxitin—Stevens-Johnson syndrome—Imiquimod—skin cancer	0.00724	0.00724	CcSEcCtD
Cefoxitin—Gastrointestinal pain—Vismodegib—skin cancer	0.00723	0.00723	CcSEcCtD
Cefoxitin—Abdominal pain—Vismodegib—skin cancer	0.00699	0.00699	CcSEcCtD
Cefoxitin—Erythema—Vemurafenib—skin cancer	0.00669	0.00669	CcSEcCtD
Cefoxitin—Haemoglobin—Imiquimod—skin cancer	0.00659	0.00659	CcSEcCtD
Cefoxitin—Thrombophlebitis—Temozolomide—skin cancer	0.00656	0.00656	CcSEcCtD
Cefoxitin—Haemorrhage—Imiquimod—skin cancer	0.00656	0.00656	CcSEcCtD
Cefoxitin—Rash maculo-papular—Fluorouracil—skin cancer	0.00655	0.00655	CcSEcCtD
Cefoxitin—Urinary tract disorder—Imiquimod—skin cancer	0.00647	0.00647	CcSEcCtD
Cefoxitin—Urethral disorder—Imiquimod—skin cancer	0.00643	0.00643	CcSEcCtD
Cefoxitin—Pruritus—Vismodegib—skin cancer	0.00625	0.00625	CcSEcCtD
Cefoxitin—Erythema multiforme—Imiquimod—skin cancer	0.0062	0.0062	CcSEcCtD
Cefoxitin—Flushing—Imiquimod—skin cancer	0.00608	0.00608	CcSEcCtD
Cefoxitin—Diarrhoea—Vismodegib—skin cancer	0.00605	0.00605	CcSEcCtD
Cefoxitin—Thrombophlebitis—Fluorouracil—skin cancer	0.00604	0.00604	CcSEcCtD
Cefoxitin—Dermatitis exfoliative—Temozolomide—skin cancer	0.00602	0.00602	CcSEcCtD
Cefoxitin—Erythema—Imiquimod—skin cancer	0.00571	0.00571	CcSEcCtD
Cefoxitin—Toxic epidermal necrolysis—Dactinomycin—skin cancer	0.00565	0.00565	CcSEcCtD
Cefoxitin—Vomiting—Vismodegib—skin cancer	0.00562	0.00562	CcSEcCtD
Cefoxitin—Rash—Vismodegib—skin cancer	0.00557	0.00557	CcSEcCtD
Cefoxitin—Dermatitis—Vismodegib—skin cancer	0.00557	0.00557	CcSEcCtD
Cefoxitin—Pancytopenia—Bleomycin—skin cancer	0.00553	0.00553	CcSEcCtD
Cefoxitin—Blood bilirubin increased—Docetaxel—skin cancer	0.0055	0.0055	CcSEcCtD
Cefoxitin—Anaphylactic shock—Vemurafenib—skin cancer	0.00546	0.00546	CcSEcCtD
Cefoxitin—Nausea—Vismodegib—skin cancer	0.00525	0.00525	CcSEcCtD
Cefoxitin—Angioedema—Imiquimod—skin cancer	0.00521	0.00521	CcSEcCtD
Cefoxitin—Pancytopenia—Dactinomycin—skin cancer	0.00515	0.00515	CcSEcCtD
Cefoxitin—Toxic epidermal necrolysis—Temozolomide—skin cancer	0.00511	0.00511	CcSEcCtD
Cefoxitin—Hypotension—Vemurafenib—skin cancer	0.0051	0.0051	CcSEcCtD
Cefoxitin—Neutropenia—Dactinomycin—skin cancer	0.00507	0.00507	CcSEcCtD
Cefoxitin—Colitis—Docetaxel—skin cancer	0.005	0.005	CcSEcCtD
Cefoxitin—Candida infection—Docetaxel—skin cancer	0.00497	0.00497	CcSEcCtD
Cefoxitin—Convulsion—Imiquimod—skin cancer	0.00494	0.00494	CcSEcCtD
Cefoxitin—Stevens-Johnson syndrome—Dactinomycin—skin cancer	0.0048	0.0048	CcSEcCtD
Cefoxitin—Haemoglobin—Bleomycin—skin cancer	0.00468	0.00468	CcSEcCtD
Cefoxitin—Pancytopenia—Temozolomide—skin cancer	0.00466	0.00466	CcSEcCtD
Cefoxitin—Haemorrhage—Bleomycin—skin cancer	0.00466	0.00466	CcSEcCtD
Cefoxitin—Neutropenia—Temozolomide—skin cancer	0.00459	0.00459	CcSEcCtD
Cefoxitin—Agranulocytosis—Dactinomycin—skin cancer	0.00452	0.00452	CcSEcCtD
Cefoxitin—Eosinophilia—Fluorouracil—skin cancer	0.00448	0.00448	CcSEcCtD
Cefoxitin—Phlebitis—Docetaxel—skin cancer	0.00438	0.00438	CcSEcCtD
Cefoxitin—Thrombophlebitis—Docetaxel—skin cancer	0.00436	0.00436	CcSEcCtD
Cefoxitin—Stevens-Johnson syndrome—Temozolomide—skin cancer	0.00434	0.00434	CcSEcCtD
Cefoxitin—Flushing—Bleomycin—skin cancer	0.00432	0.00432	CcSEcCtD
Cefoxitin—Body temperature increased—Vemurafenib—skin cancer	0.00432	0.00432	CcSEcCtD
Cefoxitin—Pancytopenia—Fluorouracil—skin cancer	0.00429	0.00429	CcSEcCtD
Cefoxitin—Dyspnoea—Imiquimod—skin cancer	0.00415	0.00415	CcSEcCtD
Cefoxitin—Erythema multiforme—Dactinomycin—skin cancer	0.00411	0.00411	CcSEcCtD
Cefoxitin—Erythema—Bleomycin—skin cancer	0.00405	0.00405	CcSEcCtD
Cefoxitin—Flushing—Dactinomycin—skin cancer	0.00403	0.00403	CcSEcCtD
Cefoxitin—Hypersensitivity—Vemurafenib—skin cancer	0.00402	0.00402	CcSEcCtD
Cefoxitin—Pain—Imiquimod—skin cancer	0.00398	0.00398	CcSEcCtD
Cefoxitin—Haemoglobin—Temozolomide—skin cancer	0.00395	0.00395	CcSEcCtD
Cefoxitin—Haemorrhage—Temozolomide—skin cancer	0.00393	0.00393	CcSEcCtD
Cefoxitin—Urinary tract disorder—Temozolomide—skin cancer	0.00388	0.00388	CcSEcCtD
Cefoxitin—Pruritus—Vemurafenib—skin cancer	0.00386	0.00386	CcSEcCtD
Cefoxitin—Urethral disorder—Temozolomide—skin cancer	0.00385	0.00385	CcSEcCtD
Cefoxitin—Gastrointestinal pain—Imiquimod—skin cancer	0.00381	0.00381	CcSEcCtD
Cefoxitin—Erythema—Dactinomycin—skin cancer	0.00378	0.00378	CcSEcCtD
Cefoxitin—Agranulocytosis—Fluorouracil—skin cancer	0.00376	0.00376	CcSEcCtD
Cefoxitin—Anaemia—Bleomycin—skin cancer	0.00375	0.00375	CcSEcCtD
Cefoxitin—Diarrhoea—Vemurafenib—skin cancer	0.00374	0.00374	CcSEcCtD
Cefoxitin—Erythema multiforme—Temozolomide—skin cancer	0.00371	0.00371	CcSEcCtD
Cefoxitin—Urticaria—Imiquimod—skin cancer	0.0037	0.0037	CcSEcCtD
Cefoxitin—Body temperature increased—Imiquimod—skin cancer	0.00368	0.00368	CcSEcCtD
Cefoxitin—Abdominal pain—Imiquimod—skin cancer	0.00368	0.00368	CcSEcCtD
Cefoxitin—Flushing—Temozolomide—skin cancer	0.00365	0.00365	CcSEcCtD
Cefoxitin—Haemoglobin—Fluorouracil—skin cancer	0.00364	0.00364	CcSEcCtD
Cefoxitin—Leukopenia—Bleomycin—skin cancer	0.00363	0.00363	CcSEcCtD
Cefoxitin—Haemorrhage—Fluorouracil—skin cancer	0.00362	0.00362	CcSEcCtD
Cefoxitin—Anaemia—Dactinomycin—skin cancer	0.00349	0.00349	CcSEcCtD
Cefoxitin—Vomiting—Vemurafenib—skin cancer	0.00347	0.00347	CcSEcCtD
Cefoxitin—Rash—Vemurafenib—skin cancer	0.00344	0.00344	CcSEcCtD
Cefoxitin—Dermatitis—Vemurafenib—skin cancer	0.00344	0.00344	CcSEcCtD
Cefoxitin—Hypersensitivity—Imiquimod—skin cancer	0.00343	0.00343	CcSEcCtD
Cefoxitin—Erythema—Temozolomide—skin cancer	0.00342	0.00342	CcSEcCtD
Cefoxitin—Toxic epidermal necrolysis—Docetaxel—skin cancer	0.0034	0.0034	CcSEcCtD
Cefoxitin—Leukopenia—Dactinomycin—skin cancer	0.00338	0.00338	CcSEcCtD
Cefoxitin—Anaphylactic shock—Bleomycin—skin cancer	0.00331	0.00331	CcSEcCtD
Cefoxitin—Pruritus—Imiquimod—skin cancer	0.0033	0.0033	CcSEcCtD
Cefoxitin—Nausea—Vemurafenib—skin cancer	0.00324	0.00324	CcSEcCtD
Cefoxitin—Thrombocytopenia—Bleomycin—skin cancer	0.00324	0.00324	CcSEcCtD
Cefoxitin—Diarrhoea—Imiquimod—skin cancer	0.00319	0.00319	CcSEcCtD
Cefoxitin—Anaemia—Temozolomide—skin cancer	0.00316	0.00316	CcSEcCtD
Cefoxitin—Erythema—Fluorouracil—skin cancer	0.00315	0.00315	CcSEcCtD
Cefoxitin—Angioedema—Temozolomide—skin cancer	0.00313	0.00313	CcSEcCtD
Cefoxitin—Pancytopenia—Docetaxel—skin cancer	0.0031	0.0031	CcSEcCtD
Cefoxitin—Hypotension—Bleomycin—skin cancer	0.00309	0.00309	CcSEcCtD
Cefoxitin—Leukopenia—Temozolomide—skin cancer	0.00306	0.00306	CcSEcCtD
Cefoxitin—Neutropenia—Docetaxel—skin cancer	0.00305	0.00305	CcSEcCtD
Cefoxitin—Thrombocytopenia—Dactinomycin—skin cancer	0.00302	0.00302	CcSEcCtD
Cefoxitin—Convulsion—Temozolomide—skin cancer	0.00296	0.00296	CcSEcCtD
Cefoxitin—Vomiting—Imiquimod—skin cancer	0.00296	0.00296	CcSEcCtD
Cefoxitin—Dyspnoea—Bleomycin—skin cancer	0.00295	0.00295	CcSEcCtD
Cefoxitin—Rash—Imiquimod—skin cancer	0.00294	0.00294	CcSEcCtD
Cefoxitin—Dermatitis—Imiquimod—skin cancer	0.00293	0.00293	CcSEcCtD
Cefoxitin—Anaemia—Fluorouracil—skin cancer	0.00291	0.00291	CcSEcCtD
Cefoxitin—Stevens-Johnson syndrome—Docetaxel—skin cancer	0.00289	0.00289	CcSEcCtD
Cefoxitin—Jaundice—Docetaxel—skin cancer	0.00284	0.00284	CcSEcCtD
Cefoxitin—Pain—Bleomycin—skin cancer	0.00283	0.00283	CcSEcCtD
Cefoxitin—Leukopenia—Fluorouracil—skin cancer	0.00282	0.00282	CcSEcCtD
Cefoxitin—Anaphylactic shock—Temozolomide—skin cancer	0.00279	0.00279	CcSEcCtD
Cefoxitin—Nausea—Imiquimod—skin cancer	0.00277	0.00277	CcSEcCtD
Cefoxitin—Thrombocytopenia—Temozolomide—skin cancer	0.00273	0.00273	CcSEcCtD
Cefoxitin—Convulsion—Fluorouracil—skin cancer	0.00273	0.00273	CcSEcCtD
Cefoxitin—Agranulocytosis—Docetaxel—skin cancer	0.00272	0.00272	CcSEcCtD
Cefoxitin—Pain—Dactinomycin—skin cancer	0.00264	0.00264	CcSEcCtD
Cefoxitin—Urticaria—Bleomycin—skin cancer	0.00263	0.00263	CcSEcCtD
Cefoxitin—Haemoglobin—Docetaxel—skin cancer	0.00263	0.00263	CcSEcCtD
Cefoxitin—Body temperature increased—Bleomycin—skin cancer	0.00262	0.00262	CcSEcCtD
Cefoxitin—Haemorrhage—Docetaxel—skin cancer	0.00261	0.00261	CcSEcCtD
Cefoxitin—Urinary tract disorder—Docetaxel—skin cancer	0.00258	0.00258	CcSEcCtD
Cefoxitin—Anaphylactic shock—Fluorouracil—skin cancer	0.00257	0.00257	CcSEcCtD
Cefoxitin—Urethral disorder—Docetaxel—skin cancer	0.00256	0.00256	CcSEcCtD
Cefoxitin—Gastrointestinal pain—Dactinomycin—skin cancer	0.00252	0.00252	CcSEcCtD
Cefoxitin—Thrombocytopenia—Fluorouracil—skin cancer	0.00252	0.00252	CcSEcCtD
Cefoxitin—Dyspnoea—Temozolomide—skin cancer	0.00249	0.00249	CcSEcCtD
Cefoxitin—Erythema multiforme—Docetaxel—skin cancer	0.00247	0.00247	CcSEcCtD
Cefoxitin—Abdominal pain—Dactinomycin—skin cancer	0.00244	0.00244	CcSEcCtD
Cefoxitin—Body temperature increased—Dactinomycin—skin cancer	0.00244	0.00244	CcSEcCtD
Cefoxitin—Hypersensitivity—Bleomycin—skin cancer	0.00244	0.00244	CcSEcCtD
Cefoxitin—Flushing—Docetaxel—skin cancer	0.00242	0.00242	CcSEcCtD
Cefoxitin—Hypotension—Fluorouracil—skin cancer	0.0024	0.0024	CcSEcCtD
Cefoxitin—Pain—Temozolomide—skin cancer	0.00239	0.00239	CcSEcCtD
Cefoxitin—Pruritus—Bleomycin—skin cancer	0.00234	0.00234	CcSEcCtD
Cefoxitin—Dyspnoea—Fluorouracil—skin cancer	0.00229	0.00229	CcSEcCtD
Cefoxitin—Gastrointestinal pain—Temozolomide—skin cancer	0.00228	0.00228	CcSEcCtD
Cefoxitin—Erythema—Docetaxel—skin cancer	0.00227	0.00227	CcSEcCtD
Cefoxitin—Hypersensitivity—Dactinomycin—skin cancer	0.00227	0.00227	CcSEcCtD
Cefoxitin—Urticaria—Temozolomide—skin cancer	0.00222	0.00222	CcSEcCtD
Cefoxitin—Abdominal pain—Temozolomide—skin cancer	0.00221	0.00221	CcSEcCtD
Cefoxitin—Body temperature increased—Temozolomide—skin cancer	0.00221	0.00221	CcSEcCtD
Cefoxitin—Pain—Fluorouracil—skin cancer	0.0022	0.0022	CcSEcCtD
Cefoxitin—Diarrhoea—Dactinomycin—skin cancer	0.00211	0.00211	CcSEcCtD
Cefoxitin—Vomiting—Bleomycin—skin cancer	0.0021	0.0021	CcSEcCtD
Cefoxitin—Anaemia—Docetaxel—skin cancer	0.0021	0.0021	CcSEcCtD
Cefoxitin—Rash—Bleomycin—skin cancer	0.00209	0.00209	CcSEcCtD
Cefoxitin—Dermatitis—Bleomycin—skin cancer	0.00208	0.00208	CcSEcCtD
Cefoxitin—Hypersensitivity—Temozolomide—skin cancer	0.00206	0.00206	CcSEcCtD
Cefoxitin—Urticaria—Fluorouracil—skin cancer	0.00204	0.00204	CcSEcCtD
Cefoxitin—Leukopenia—Docetaxel—skin cancer	0.00204	0.00204	CcSEcCtD
Cefoxitin—Body temperature increased—Fluorouracil—skin cancer	0.00203	0.00203	CcSEcCtD
Cefoxitin—Pruritus—Temozolomide—skin cancer	0.00197	0.00197	CcSEcCtD
Cefoxitin—Convulsion—Docetaxel—skin cancer	0.00197	0.00197	CcSEcCtD
Cefoxitin—Nausea—Bleomycin—skin cancer	0.00197	0.00197	CcSEcCtD
Cefoxitin—Vomiting—Dactinomycin—skin cancer	0.00196	0.00196	CcSEcCtD
Cefoxitin—Rash—Dactinomycin—skin cancer	0.00195	0.00195	CcSEcCtD
Cefoxitin—Diarrhoea—Temozolomide—skin cancer	0.00191	0.00191	CcSEcCtD
Cefoxitin—Hypersensitivity—Fluorouracil—skin cancer	0.00189	0.00189	CcSEcCtD
Cefoxitin—Anaphylactic shock—Docetaxel—skin cancer	0.00186	0.00186	CcSEcCtD
Cefoxitin—Nausea—Dactinomycin—skin cancer	0.00183	0.00183	CcSEcCtD
Cefoxitin—Pruritus—Fluorouracil—skin cancer	0.00182	0.00182	CcSEcCtD
Cefoxitin—Thrombocytopenia—Docetaxel—skin cancer	0.00182	0.00182	CcSEcCtD
Cefoxitin—Vomiting—Temozolomide—skin cancer	0.00177	0.00177	CcSEcCtD
Cefoxitin—Rash—Temozolomide—skin cancer	0.00176	0.00176	CcSEcCtD
Cefoxitin—Diarrhoea—Fluorouracil—skin cancer	0.00176	0.00176	CcSEcCtD
Cefoxitin—Dermatitis—Temozolomide—skin cancer	0.00176	0.00176	CcSEcCtD
Cefoxitin—Hypotension—Docetaxel—skin cancer	0.00173	0.00173	CcSEcCtD
Cefoxitin—Nausea—Temozolomide—skin cancer	0.00166	0.00166	CcSEcCtD
Cefoxitin—Dyspnoea—Docetaxel—skin cancer	0.00165	0.00165	CcSEcCtD
Cefoxitin—Vomiting—Fluorouracil—skin cancer	0.00164	0.00164	CcSEcCtD
Cefoxitin—Rash—Fluorouracil—skin cancer	0.00162	0.00162	CcSEcCtD
Cefoxitin—Dermatitis—Fluorouracil—skin cancer	0.00162	0.00162	CcSEcCtD
Cefoxitin—Pain—Docetaxel—skin cancer	0.00159	0.00159	CcSEcCtD
Cefoxitin—Nausea—Fluorouracil—skin cancer	0.00153	0.00153	CcSEcCtD
Cefoxitin—Gastrointestinal pain—Docetaxel—skin cancer	0.00152	0.00152	CcSEcCtD
Cefoxitin—Abdominal pain—Docetaxel—skin cancer	0.00147	0.00147	CcSEcCtD
Cefoxitin—Body temperature increased—Docetaxel—skin cancer	0.00147	0.00147	CcSEcCtD
Cefoxitin—Hypersensitivity—Docetaxel—skin cancer	0.00137	0.00137	CcSEcCtD
Cefoxitin—Pruritus—Docetaxel—skin cancer	0.00131	0.00131	CcSEcCtD
Cefoxitin—Diarrhoea—Docetaxel—skin cancer	0.00127	0.00127	CcSEcCtD
Cefoxitin—Vomiting—Docetaxel—skin cancer	0.00118	0.00118	CcSEcCtD
Cefoxitin—Rash—Docetaxel—skin cancer	0.00117	0.00117	CcSEcCtD
Cefoxitin—Dermatitis—Docetaxel—skin cancer	0.00117	0.00117	CcSEcCtD
Cefoxitin—Nausea—Docetaxel—skin cancer	0.0011	0.0011	CcSEcCtD
